Literature DB >> 21464073

Challenges for pharmaceutical industry: new partnerships for sustainable human health.

Jackie Hunter1.   

Abstract

The healthcare burden is increasing in both the developed and the developing world and there is widespread acceptance that the historical pharmaceutical business model is not sustainable. In order to meet the healthcare challenge, companies and academia need to develop new business models to increase the probability of success and decrease the cost of failure. New partnerships have already emerged in the area of neglected diseases and other models for diseases of the developed world are emerging.
© 2011 Royal Society

Entities:  

Mesh:

Year:  2011        PMID: 21464073     DOI: 10.1098/rsta.2010.0377

Source DB:  PubMed          Journal:  Philos Trans A Math Phys Eng Sci        ISSN: 1364-503X            Impact factor:   4.226


  5 in total

Review 1.  Introducing Therioepistemology: the study of how knowledge is gained from animal research.

Authors:  Joseph P Garner; Brianna N Gaskill; Elin M Weber; Jamie Ahloy-Dallaire; Kathleen R Pritchett-Corning
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

Review 2.  The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it?

Authors:  Joseph P Garner
Journal:  ILAR J       Date:  2014

Review 3.  Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Authors:  Remco L A de Vrueh; Daan J A Crommelin
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

Review 4.  Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients.

Authors:  Magdalini Papadaki
Journal:  Front Med (Lausanne)       Date:  2017-05-29

5.  Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study.

Authors:  Ye Lim Jung; JeeNa Hwang; Hyoung Sun Yoo
Journal:  Global Health       Date:  2020-09-10       Impact factor: 4.185

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.